Cytomegalovirus Infections in Children with Primary and Secondary Immune Deficiencies
Open Access
Abstract
Cytomegalovirus (CMV) is a human herpes virus that causes significant morbidity and mortality in immunosuppressed children. CMV primary infection causes a clinically mild disease in healthy children, usually in early childhood; the virus then utilises several mechanisms to establish host latency, which allows for periodic reactivation, particularly when the host is immunocompromised. It is this reactivation that is responsible for the significant morbidity and mortality in immunocompromised children. We review CMV infection in the primary immunodeficient host, including early identification of these infants by newborn screening to allow for CMV infection prevention strategies. Furthermore, clinical CMV is discussed in the context of children treated with secondary immunodeficiency, particularly paediatric cancer patients and children undergoing haematopoietic stem cell transplant (HSCT). Treatments for CMV are highlighted and include CMV immunotherapy.Keywords
This publication has 93 references indexed in Scilit:
- Cytomegalovirus in the Neonate: Immune Correlates of Infection and ProtectionJournal of Immunology Research, 2013
- Impact of viral reactivations in the era of pre-emptive antiviral drug therapy following allogeneic haematopoietic SCT in paediatric recipientsBone Marrow Transplantation, 2012
- Glycoprotein B Vaccine Is Capable of Boosting Both Antibody and CD4 T-Cell Responses to Cytomegalovirus in Chronically Infected WomenThe Journal of Infectious Diseases, 2011
- Antiviral Drug Resistance of Human CytomegalovirusClinical Microbiology Reviews, 2010
- How we treat cytomegalovirus in hematopoietic cell transplant recipientsBlood, 2009
- Donor CMV Serostatus Not Predictive of Relapse in D-/R- Pediatric HCTTransplantation and Cellular Therapy, 2009
- Vaccine Prevention of Maternal Cytomegalovirus InfectionNew England Journal of Medicine, 2009
- Growth and Drug Resistance Phenotypes Resulting from Cytomegalovirus DNA Polymerase Region III Mutations Observed in Clinical SpecimensAntimicrobial Agents and Chemotherapy, 2007
- Topics in herpesvirus genomics and evolutionVirus Research, 2006
- CidofovirDrugs, 1996